{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:20:20Z","timestamp":1794856820108,"version":"4.9.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2004,6,15]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Background\u2014<\/jats:italic>\n            <\/jats:bold>\n            Recent studies suggest that aldosterone may impair endothelium-dependent vascular function through suppression of nitric oxide formation. Assessments of forearm blood flow or arterial compliance suggest a similar effect in humans. The present study was designed to determine whether chronic aldosterone excess in subjects with resistant hypertension impairs endothelium-dependent vascular reactivity as indexed by direct assessment of brachial artery flow-mediated dilation (FMD).\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Methods and Results\u2014<\/jats:italic>\n            <\/jats:bold>\n            Consecutive subjects (n=80) with resistant hypertension were prospectively evaluated with an early-morning ratio of plasma aldosterone to plasma renin activity and 24-hour urinary aldosterone and sodium. Changes in brachial artery diameter during reactive hyperemia were measured by high-resolution ultrasound. Hyperaldosteronism was diagnosed on the basis of a renin activity &lt;1.0 ng \u00b7 mL\n            <jats:sup>\u22121<\/jats:sup>\n            \u00b7 h\n            <jats:sup>\u22121<\/jats:sup>\n            , urinary aldosterone &gt;12 \u03bcg\/24 h, and urinary sodium &gt;200 mEq\/24 h. FMD was significantly lower in 36 subjects with hyperaldosteronism (1.8\u00b11.3% versus 3.9\u00b11.9% from baseline;\n            <jats:italic>P<\/jats:italic>\n            &lt;0.0001) compared with the 44 subjects without hyperaldosteronism. FMD was negatively and significantly correlated with plasma aldosterone (\n            <jats:italic>r<\/jats:italic>\n            =\u22120.38,\n            <jats:italic>P<\/jats:italic>\n            =0.0006), 24-hour urinary aldosterone (\n            <jats:italic>r<\/jats:italic>\n            =\u22120.49,\n            <jats:italic>P<\/jats:italic>\n            &lt;0.0001), and ratio of plasma aldosterone to plasma renin activity (\n            <jats:italic>r<\/jats:italic>\n            =\u22120.43,\n            <jats:italic>P<\/jats:italic>\n            &lt;0.0001) but was independent of blood pressure, age, and body mass index. In 30 subjects, 3 months of treatment with spironolactone significantly increased FMD (2.5\u00b11.7 versus 6.0\u00b12.0%;\n            <jats:italic>P<\/jats:italic>\n            &lt;0.0001) independently of blood pressure change.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusions\u2014<\/jats:italic>\n            <\/jats:bold>\n            These data demonstrate a strong association between aldosterone excess and impaired endothelial function in human subjects as indexed by flow-mediated arterial vasodilation. These results suggest that chronic aldosteronism may have a blood pressure\u2013independent effect on cardiovascular disease progression in subjects with resistant hypertension.\n          <\/jats:p>","DOI":"10.1161\/01.cir.0000129307.26791.8e","type":"journal-article","created":{"date-parts":[[2004,6,8]],"date-time":"2004-06-08T00:29:48Z","timestamp":1086654588000},"page":"2857-2861","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":174,"title":["Impaired Endothelium-Dependent Flow-Mediated Vasodilation in Hypertensive Subjects With Hyperaldosteronism"],"prefix":"10.1161","volume":"109","author":[{"given":"Mari K.","family":"Nishizaka","sequence":"first","affiliation":[{"name":"From the Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Amin","family":"Zaman","sequence":"additional","affiliation":[{"name":"From the Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon A.","family":"Green","sequence":"additional","affiliation":[{"name":"From the Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry Y.","family":"Renfroe","sequence":"additional","affiliation":[{"name":"From the Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Calhoun","sequence":"additional","affiliation":[{"name":"From the Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/0922-4106(95)90018-7"},{"key":"e_1_3_2_2_2","first-page":"351","volume":"39","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000015854.60710.10"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(97)00301-4"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1998.1099"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.21.6.929"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.101.6.594"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(96)90311-7"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)93147-F"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00189-7"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02894-2"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000040261.30455.b6"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-0279"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2001.00496.x"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01746-6"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/174182670100800512"},{"key":"e_1_3_2_17_2","first-page":"925","volume":"19","year":"2003","journal-title":"Am J Hypertens"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.82.5.2225374"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80353-1"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200103001-00005"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000070956.57418.22"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.33.1.575"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00333-4"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.0000129307.26791.8E","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T18:57:04Z","timestamp":1715021824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.0000129307.26791.8E"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,15]]},"references-count":24,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2004,6,15]]}},"alternative-id":["10.1161\/01.CIR.0000129307.26791.8E"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.0000129307.26791.8e","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,15]]},"assertion":[{"value":"2004-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}